pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,995 catalysts · 6,645 phase readout · 2,350 8k filing · 388 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 0 catalysts2026-08-19: 0 catalysts2026-08-20: 9 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: 8k filing×type: phase readout×clear all
type
  • phase readout6,645
  • 8k filing2,350
  • earnings388
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT05931874: Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors

Sponsor: Northwestern University. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07550374: Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery

Sponsor: iRegene Therapeutics Co., Ltd.. Phase: PHASE1. Conditions: Parkinson's Disease (PD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07584642: Efficacy and Safety of HA35 Gel Nighttime Occlusive Application for TMD Pain

Sponsor: Nakhia Impex LLC. Phase: NA. Conditions: Temporomandibular Joint Disorders, TMD, Temporomandibular Joint Pain, Jaw Muscle Over-Tension, Bruxism

full page →ctgov ↗
›RECRUITINGphase readoutNCT07641842: Shoulder RA Survey Study

Sponsor: University Health Network, Toronto. Phase: . Conditions: Nerve Block

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07696442: Sleep, Music, And Research Trial 2.0

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Epilepsy in Children, Epilepsy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07312942: Effects of Controlled Breathing Added to Therapeutic Exercise in Multiple Myeloma

Sponsor: Universidad Complutense de Madrid. Phase: NA. Conditions: Multiple Myeloma, Breathing Techniques, Breathing Exercises, Exercise Activity, Diaphragmatic Breathing

full page →ctgov ↗
›RECRUITINGphase readoutNCT06601686: Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04314570: Saphenous Nerve Block After Tibial Plateau ORIF

Sponsor: Stanford University. Phase: NA. Conditions: Tibial Plateau Fracture, Pain, Postoperative

full page →ctgov ↗
›RECRUITINGphase readoutNCT07467070: Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific Low Backache

Sponsor: University of Health Sciences Lahore. Phase: NA. Conditions: Low Back Pain, Postural Control, Core Strength, Flexibility, Pilates, Non-specific Low Back Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06931470: A Pilot Feasibility and Acceptability Study of Remote ExerciSe Training mOdalities (PRESTO)

Sponsor: NYU Langone Health. Phase: NA. Conditions: Cardiovascular Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07298070: Functional and Aesthetic Outcomes Following Lower Lip Reconstruction

Sponsor: Hôpital NOVO. Phase: . Conditions: Lower Lip Tissue Loss, Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT02706561: Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Prostate Cancer, Erectile Dysfunction

full page →ctgov ↗
›COMPLETEDphase readoutNCT07321561: Effect of a Motor Support Program in Children With Autism

Sponsor: Istanbul Aydın University. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07727161: 3D Printing in Preoperative Planning in Thoracic and Lumbar Spine Trauma

Sponsor: Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.. Phase: NA. Conditions: Spine Trauma (Thoracic and Lumbar)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06994442: Optimizing Pain Treatment in Children On Mechanical Ventilation

Sponsor: Weill Medical College of Cornell University. Phase: PHASE3. Conditions: Mechanical Ventilation, Pediatric Acute Respiratory Failure, Analgesics, Opioid, Sedation and Analgesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05288842: Tanycytes in Alzheimer's Disease and Frontotemporal Dementia

Sponsor: University Hospital, Lille. Phase: . Conditions: Alzheimer Disease, Frontotemporal Dementia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07709442: Songling Xuemaikang in Hypertension and Insomnia Evaluation(SHINE)

Sponsor: Jing Liu. Phase: NA. Conditions: Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07518186: A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Multiple Myeloma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07074886: A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)

Sponsor: Hoffmann-La Roche. Phase: PHASE2. Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07498686: Plasma a-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Neurodegeneration Disease

Sponsor: Xuanwu Hospital, Beijing. Phase: . Conditions: RT-QuIC

full page →ctgov ↗
›RECRUITINGphase readoutNCT07536386: Self-balancing Personal Exoskeleton for SCI (WIP)

Sponsor: Wandercraft. Phase: NA. Conditions: Spinal Cord Injuries, Paraplegia and Tetraplegia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05632770: A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems

Sponsor: University of Washington. Phase: NA. Conditions: PTSD, Physical Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07271342: Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China

Sponsor: Beijing Tiantan Hospital. Phase: . Conditions: Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT07575542: The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With Mechanical

Sponsor: Istinye University. Phase: NA. Conditions: Mechanical Neck Pain, Tennis, Pain, Manual Therapy, Therapeutic Exercise

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07715942: Effect of Bioactive Resin Material Containing S-PRG Filler on White Spot Lesions

Sponsor: Jordan University of Science and Technology. Phase: NA. Conditions: White Spot Lesion of Tooth

full page →ctgov ↗
›COMPLETEDphase readoutNCT02553486: Internationally Adopted Children Quality of Life

Sponsor: Nantes University Hospital. Phase: . Conditions: Children, Quality of Life

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07625670: Clinical Study to Evaluate Remineralization Using an in Situ Model.

Sponsor: Colgate Palmolive. Phase: PHASE3. Conditions: Remineralization, Enamel Lesions, Enamel Subsurface Lesion

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07312370: Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing

Sponsor: LanZhou University. Phase: PHASE4. Conditions: Early Gastric Cancer, Gastric Dysplasia, Gastric Neoplasms, Peptic Ulcer With Haemorrhage, Gastric Ulcer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06480370: Optimization of Transcranial Motor Evoked Potentials in Supratentorial Surgeries

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Surgery

full page →ctgov ↗
›COMPLETEDphase readoutNCT01802242: Tumor TARGET Prostate Cancer

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07385742: Botulinum Toxin Versus Platelet Rich Fibrin for TMJ Internal Derangement

Sponsor: Suez Canal University. Phase: NA. Conditions: Temporomandibular Joint Internal Derangement, Temporomandibular Joint Disorders, Temporomandibular Disorders (TMD), TMJ Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07507942: Assessment of Femoral Failure Load and Fracture Risk in Rare Bone Disorders Using MEKANOS Tool. Case Study of Fibrous Dysplasia of Bone/McCune Albright Syndrome

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Fibrous Dysplasia/McCune-Albright Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07436442: THE IMPACT OF NURSİNG CARE ON COMPLİCATİON İN PEG PATİENTS

Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. Phase: NA. Conditions: Difficulty Swallowing

full page →ctgov ↗
›RECRUITINGphase readoutNCT07368686: Topical Multivitamin Serum for Skin Heath

Sponsor: Erevna Innovations Inc.. Phase: PHASE4. Conditions: Aesthetic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07684742: Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome

Sponsor: Gyeongsang National University Hospital. Phase: PHASE4. Conditions: Acute Coronary Syndromes, STEMI, NSTEMI, Unstable Angina

full page →ctgov ↗
›COMPLETEDphase readoutNCT00445627: Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Obesity, Overweight, Diabetes Mellitus, Type 2

full page →ctgov ↗
›RECRUITINGphase readoutNCT07226427: A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

Sponsor: Stemline Therapeutics, Inc.. Phase: PHASE1. Conditions: Platinum-resistant Ovarian Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06118086: Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

Sponsor: Remix Therapeutics. Phase: PHASE1. Conditions: Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT03693170: Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer

Sponsor: Pierre Fabre Medicament. Phase: PHASE2. Conditions: BRAF V600E-mutant Metastatic Colorectal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06688786: A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Locally Advanced Rectal Cancer (LARC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07680842: Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Drug-Resistant Epilepsy, Epilepsy, Epilepsy (Treatment Refractory), Epilepsy Comorbidities, Epilepsy, Drug Resistant, Epilepsy, Generalized, Epilepsy, Focal

full page →ctgov ↗
›COMPLETEDphase readoutNCT07023042: Kinesio-Taping vs. Usual Care for Malignant Bowel Obstruction With Ascites

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Malignant Bowel Obstruction, Ascites, Advanced Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07596186: Predict Early Cognitive Changes in a Healthy Elderly Population by Passively Recording Sensor Data From Mobile Devices

Sponsor: Soroka University Medical Center. Phase: . Conditions: Cognitive Decline, Mild

full page →ctgov ↗
›RECRUITINGphase readoutNCT04772170: Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Influenza, Respiratory Virus, Coronavirus

full page →ctgov ↗
›RECRUITINGphase readoutNCT06329570: Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Sponsor: NaviFUS Corporation. Phase: PHASE1. Conditions: Glioblastoma Multiforme, Glioblastoma, Glioma, Brain Tumor, Neoplasms, Neoplasms, Nerve Tissue

full page →ctgov ↗
›RECRUITINGphase readoutNCT07755670: Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRI

Sponsor: Second Xiangya Hospital of Central South University. Phase: . Conditions: Hidradenitis Suppurativa (HS)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04845542: Promoting Resilience in Stroke Survivor-carepartner Dyads (ReStoreD)

Sponsor: University of Utah. Phase: NA. Conditions: Stroke, Depression, Anxiety, Coping Skills, Couples

full page →ctgov ↗
›RECRUITINGphase readoutNCT07158242: A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Moderately to Severely Active Ulcerative Colitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04126070: Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Sponsor: Xiao X. Wei, MD. Phase: PHASE2. Conditions: Hormone Sensitive Prostate Cancer, Prostate Adenocarcinoma, Metastasis Prostate Adenocarcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05757570: An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

Sponsor: Alpine Immune Sciences, Inc.. Phase: PHASE1. Conditions: Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia, Cold Agglutinin Disease

full page →ctgov ↗
← prev
page 179 of 180
next →